REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,761,000 | +24.5% | 17,500 | +75.0% | 0.62% | +9.9% |
| Q2 2021 | $1,415,000 | +1.4% | 10,000 | -28.6% | 0.56% | +12.3% |
| Q1 2021 | $1,396,000 | -41.5% | 14,000 | -8.5% | 0.50% | -27.1% |
| Q2 2020 | $2,387,000 | -29.6% | 15,300 | -34.9% | 0.69% | -58.0% |
| Q1 2020 | $3,392,000 | -56.3% | 23,500 | -38.2% | 1.64% | -14.6% |
| Q4 2019 | $7,768,000 | +115.0% | 38,000 | -15.6% | 1.92% | -26.2% |
| Q3 2019 | $3,613,000 | – | 45,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |